This multicenter, double-blind, randomized, parallel-group fixed-dose study of 8 weeks' duration was performed to define the maximum tolerated dose of nateglinide in a prediabetic population.

nateglinide + rosiglitazone; , placebo and rosiglitazone. Plasma glucose (A) and immunoreactive insulin (IRI) (B) during standardized meal challenges performed at week 0 and after 24 weeks of ...

Levy JC. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care. 2001 Jul;24(7):1221-5. [4]Shukla AP， Dickison M， ...

Levy JC. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care. 2001 Jul;24(7):1221-5. [4]Shukla AP ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Objectives Older adults are particularly vulnerable to adverse effects from concurrent alcohol and medication use. However, there is limited evidence regarding the prevalence of these adverse outcomes ...